Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-054709

CFO & Executive Vice President acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dier Mardi · CFO & Executive Vice President

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-12 Grant or award : show line 1 in the form +40,000 40,000 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-10-12 Grant or award : show line 2 in the form Stock Option (Right to Buy) +40,000 $95.50 2030-10-12 40,000 40,000 D
Loading xslF345X03/doc4.xml…